NCT06213805Completed
Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery
Source: ClinicalTrials.gov · Last updated 1 Apr 2026
Brief summary (registry, in English)
The main objective is to evaluate the effectiveness of MIMS in patients with an indication for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess safety. The investigating ophthalmologist will follow the patients and collect clinical data in order to identify the benefits and complications of MIMS. Patients are expected to experience fewer complications compared to traditional glaucoma surgery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 23 (actual)
- First submitted
- 10 Jan 2024
- Start date
- 15 Jan 2024
- Primary completion date
- 26 Mar 2026
- Lead sponsor
- Hôpital Privé de la Baie
- Diseases
- Glaucoma
- NCT number
- NCT06213805
What you commit to
- Study type: Interventional
- Participants enrolled: 23
- From 15 Jan 2024 to the primary completion date, 26 Mar 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of intraocular surgery (unless cataract surgery), history of trauma, or conjunctival scarring in the quadrant planned for surgery
Lab values
- Visual acuity lower than "counts fingers" ", closure of the iridocorneal angle (and angle-closure glaucoma unless associated cataract surgery), neovascular glaucoma or neovascularization of the iris, pachymetry \< 490 μm or \> 620 μm.
Other
- Presence of other ophthalmological pathologies (except cataract)
- Presence of severe systemic pathologies, pregnant or breastfeeding woman
Who the study is looking for
- Patients ≥ 18 years old who agree to participate in the study having signed informed consent
- Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and open iridocorneal angle ( trabecular meshwork visible on gonioscopy, Shaffer classification grade 3-4) and healthy and mobile conjunctiva (without scars or adhesions).
- Chronic angle closure glaucoma with indication for combined glaucoma and cataract surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Privé de la Baie Coordinator of this site? Confirm its status | Avranches | France | Unknown status |
| Clinique Thiers Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
| Fondation Rothschild Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.